Skip to content
WeighLab

MaxLife vs Curex

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

MaxLife

Provider comparison

Shoppers comparing a month-to-month GLP-1 plan with a discounted three-month introduction.

Semaglutide / month
$155/moMonth to month; discounted 3-month starter available, compounded
Tirzepatide / month
$195/moMonth to month; discounted 3-month starter available, compounded
Index 76/100 · Grade CChecked October 2026

Curex

Provider comparison

People who want a low-cost first month and an oral option nationwide, and who will either pay monthly or prepay a year for the lower rate.

Semaglutide / month
$299/moMonth-to-month (first month $49; $199/mo prepaid for a year)
Tirzepatide / month
$399/moMonth-to-month (first month $149; $299/mo prepaid for a year)
Index 75/100 · Grade C

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

MaxLife has the higher Cost-Efficiency Index: 76/100 versus 75/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

Check the difference in state access

MaxLife
All 50 states
Curex
All 50 states (California: oral tablet only, no injectable)

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

MaxLife

Curex

Semaglutide / month
MaxLife: $155/moMonth to month; discounted 3-month starter available, compounded
Curex: $299/moMonth-to-month (first month $49; $199/mo prepaid for a year)
Tirzepatide / month
MaxLife: $195/moMonth to month; discounted 3-month starter available, compounded
Curex: $399/moMonth-to-month (first month $149; $299/mo prepaid for a year)
Semaglutide / year (modeled)
MaxLife: $1,860
Curex: $3,588
Tirzepatide / year (modeled)
MaxLife: $2,340
Curex: $4,788
State availability
MaxLife: All 50 states
Curex: All 50 states (California: oral tablet only, no injectable)
Oral / sublingual option listed
MaxLife: Not listed
Curex: Yes
Brand-name access listed
MaxLife: Not confirmed
Curex: Not confirmed
Provider facts checked
MaxLife: October 2026
Curex: See full review

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

MaxLife

Shoppers comparing a month-to-month GLP-1 plan with a discounted three-month introduction.

Reasons to consider it

  • Standing monthly rates are published alongside Starter Kits: $267 for three semaglutide months or $360 for three tirzepatide months, then the regular monthly rate
  • The FAQ says all fifty states are served and names dispensing partners including Southend, Red Rock and Hallandale
  • Medication, supplies and priority shipping are included, with provider messaging and dose reviews

What to weigh up

  • The lowest advertised prices require a three-month Starter Kit paid upfront; renewal is $155 for semaglutide or $195 for tirzepatide
  • Cancellation requires at least thirty days of notice, and medication costs are non-refundable
  • No dose-by-dose price ladder or named medical director is published; ask whether a higher dose changes the membership price

Regulatory note: the FDA issued a warning letter to MaxLife Technologies Inc. dba Maxlife in February 2026. We still list and link to MaxLife; you should know the letter is on the public record before you decide.

Curex

People who want a low-cost first month and an oral option nationwide, and who will either pay monthly or prepay a year for the lower rate.

Reasons to consider it

  • Discounted first month well below the ongoing rate — $49 for semaglutide, $149 for tirzepatide
  • Publishes a plain price table: monthly rates, plus a prepaid-year option at $199 (semaglutide) or $299 (tirzepatide) a month
  • Nationwide enrollment (all 50 states) plus an oral/sublingual route as an alternative to injections

What to weigh up

  • The 'From $199/mo' headline is the prepaid-year rate ($2,388 up front); paid monthly, semaglutide is $299 and tirzepatide $399
  • California residents cannot get the injectable route at all — oral tablets only, despite the 'all 50 states' enrollment claim
  • Named clinical leadership is disclosed in the context of Curex's original allergy-clinic business, not confirmed as GLP-1-specific prescribers

Regulatory note: the FDA issued a warning letter to Curex in September 2025. We still list and link to Curex; you should know the letter is on the public record before you decide.

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

MaxLifeCurex
Normalized Cost/Month
MaxLife:
74/100
Curex:
52/100
Price Transparency
MaxLife:
92/100
Curex:
75/100
Nationwide Access
MaxLife:
86/100
Curex:
90/100
Formulation Options
MaxLife:
66/100
Curex:
84/100
Clinical Oversight
MaxLife:
75/100
Curex:
80/100
Contract Flexibility
MaxLife:
53/100
Curex:
80/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.